Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-07-25 | 0.00 | 0.00 |
Q2 2022 | 2022-06-30 | 0.00 | 0.00 |
Q1 2022 | 2022-04-25 | 2.15 | 2.15 |
Q4 2021 | 2022-02-24 | 2.95 | 2.95 |
Q3 2021 | 2021-10-25 | 2.67 | 2.67 |
Q2 2021 | 2021-07-26 | 3.76 | 3.76 |
Q1 2021 | 2021-04-26 | 2.44 | 2.44 |
Q4 2020 | 2021-02-25 | 3.59 | 3.59 |
Q3 2020 | 2020-10-29 | 2.88 | 2.88 |
Q2 2020 | 2020-07-27 | 2.93 | 2.93 |
2016-06-29 | Reiterated Rating | Credit Suisse | Hold | $140.00 |
2016-06-29 | Reiterated Rating | Credit Suisse Group AG | Hold | $140.00 |
2016-06-13 | Upgrade | Ladenburg Thalmann | Not Rated to Outperform | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
2016-04-30 | Reiterated Rating | RBC Capital | Buy | |
2016-04-30 | Reiterated Rating | Royal Bank Of Canada | Buy | |
2016-04-29 | Boost Price Target | RBC Capital | Outperform | $150.00 to $157.00 |
2016-04-28 | Reiterated Rating | Mizuho | Buy | $140.00 to $150.00 |
2016-04-21 | Downgrade | Standpoint Research | Buy to Hold | |
2016-03-29 | Upgrade | Wells Fargo | Market Perform to Outperform | |
2016-03-29 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | |
2016-03-02 | Upgrade | Sterne Agee CRT | Underperform to Neutral | $144.00 |
2016-02-29 | Lower Price Target | Susquehanna | $154.00 to $136.00 | |
2016-02-26 | Lower Price Target | Wedbush | Neutral | $141.00 to $127.00 |
2016-02-10 | Upgrade | Standpoint Research | Hold to Buy | $132.00 |
2016-01-22 | Lower Price Target | Mizuho | Buy | $166.00 to $140.00 |
2015-12-17 | Reiterated Rating | Credit Suisse | Hold | |
2015-12-16 | Initiated Coverage | Credit Suisse | Neutral | $129.00 |
2015-10-30 | Reiterated Rating | Barclays | Hold | |
2015-10-30 | Reiterated Rating | Barclays PLC | Hold | |
2015-10-29 | Lower Price Target | Raymond James | Outperform | $160.00 to $145.00 |
2015-10-29 | Lower Price Target | Leerink Swann | Outperform | $165.00 to $155.00 |
2015-10-29 | Lower Price Target | Barclays | Equal Weight | $145.00 to $135.00 |
2015-10-29 | Reiterated Rating | RBC Capital | Outperform | $161.00 to $150.00 |
2015-10-29 | Lower Price Target | Raymond James Financial Inc. | Outperform | $160.00 to $145.00 |
2015-10-19 | Lower Price Target | Susquehanna | Positive | $167.00 to $154.00 |
2015-10-08 | Reiterated Rating | Barclays | Equal Weight | $156.00 to $145.00 |
2015-10-02 | Initiated Coverage | Citigroup Inc. | Neutral | $134.00 |
2015-10-01 | Upgrade | KeyBanc | Sector Weight to Overweight | $145.00 |
2015-10-01 | Upgrade | KeyCorp | Sector Weight to Overweight | $145.00 |
2015-09-21 | Reiterated Rating | Leerink Swann | Outperform | $165.00 |
2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $170.00 |
2015-08-05 | Reiterated Rating | RBC Capital | Buy | |
2015-08-04 | Boost Price Target | RBC Capital | Outperform | $135.00 to $161.00 |
2015-08-03 | Reiterated Rating | Leerink Swann | Buy | $155.00 to $165.00 |
2015-08-03 | Reiterated Rating | Barclays | Equal Weight | $128.00 to $156.00 |
2015-07-31 | Reiterated Rating | Mizuho | Buy | $162.00 to $166.00 |
2015-07-16 | Downgrade | KeyBanc | Overweight | |
2015-07-01 | Initiated Coverage | Mizuho | Buy | $140.00 to $162.00 |
2015-06-26 | Boost Price Target | Leerink Swann | $150.00 to $155.00 | |
2015-06-10 | Initiated Coverage | Wedbush | Neutral | $141.00 |
2015-06-10 | Initiated Coverage | Janney Montgomery Scott | Neutral | $141.00 |
2015-06-05 | Reiterated Rating | Leerink Swann | Outperform | $140.00 to $150.00 |
2015-06-05 | Initiated Coverage | Goldman Sachs | Neutral | $140.00 |
2015-06-05 | Initiated Coverage | Goldman Sachs Group Inc. | Neutral | $140.00 |
2015-05-04 | Reiterated Rating | Credit Suisse | Outperform | $126.00 to $134.00 |
2015-04-29 | Boost Price Target | Barclays | Equal Weight | $119.00 to $128.00 |
2015-04-28 | Boost Price Target | Mizuho | Buy | $136.00 to $140.00 |
2015-04-01 | Downgrade | Sterne Agee CRT | Neutral to Underperform | $136.00 to $98.00 |
2015-03-27 | Boost Price Target | Mizuho | Buy | $125.00 to $136.00 |
2015-03-02 | Reiterated Rating | Citigroup Inc. | Buy | $120.00 to $135.00 |
2015-01-08 | Set Price Target | Credit Suisse | Outperform | $118.00 to $124.00 |
2015-01-08 | Downgrade | Barclays | Overweight to Equal Weight | $123.00 to $119.00 |
2014-12-18 | Initiated Coverage | Sterne Agee CRT | Neutral | $110.00 |
2014-10-29 | Reiterated Rating | Barclays | Overweight | $121.00 to $123.00 |
2014-10-28 | Reiterated Rating | Deutsche Bank | Buy | $125.00 |
2014-10-28 | Boost Price Target | Mizuho | Buy | $115.00 to $120.00 |
2014-10-28 | Reiterated Rating | Deutsche Bank AG | Buy | $125.00 |
2014-10-16 | Boost Price Target | Robert W. Baird | Outperform | $121.00 to $127.00 |
2014-09-29 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $105.00 to $123.00 |
2014-09-12 | Initiated Coverage | Leerink Swann | Outperform | |
2014-09-09 | Reiterated Rating | Deutsche Bank | Buy | $115.00 to $125.00 |
2014-07-28 | Reiterated Rating | Citigroup Inc. | Buy | $95.00 to $120.00 |
2014-07-28 | Boost Price Target | Barclays | Overweight | $95.00 to $121.00 |
2014-07-28 | Boost Price Target | RBC Capital | Outperform | $95.00 to $131.00 |
2014-07-25 | Reiterated | UBS | Buy | $108 to $115 |
2014-07-25 | Boost Price Target | Mizuho | Buy | $104.00 to $115.00 |
2014-07-25 | Reiterated Rating | Bank of America | Buy | $106.00 to $113.00 |
2014-07-25 | Boost Price Target | Credit Suisse | Outperform | $95.00 to $118.00 |
2014-07-25 | Reiterated Rating | Bank of America Corp. | Buy | $106.00 to $113.00 |
2014-07-24 | Reiterated Rating | Deutsche Bank | Buy | $97.00 to $105.00 |
2014-06-26 | Boost Price Target | KeyBanc | Buy | $92.00 to $105.00 |
2014-06-03 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $90.00 to $97.00 |
2014-06-03 | Upgrade | Avondale Partners | Market Perform to Outperform | $91.00 to $104.00 |
2014-05-21 | Boost Price Target | Mizuho | Buy | $98.00 to $104.00 |
2014-05-13 | Reiterated Rating | Deutsche Bank | Buy | $92.00 |
2014-05-06 | Upgrade | Susquehanna | Neutral to Positive | $105.00 to $88.00 |
2014-04-28 | Boost Price Target | BMO Capital Markets | $85.00 to $90.00 | |
2014-04-28 | Boost Price Target | Barclays | $91.00 to $95.00 | |
2014-04-28 | Boost Price Target | KeyBanc | Buy | $86.00 to $92.00 |
2014-04-28 | Reiterated Rating | FBR & Co. | Outperform | $96.00 |
2014-04-28 | Upgrade | Susquehanna | Neutral to Positive | $88.00 to $105.00 |
2014-04-28 | Boost Price Target | RBC Capital | Outperform | $90.00 to $95.00 |
2014-03-31 | Initiated Coverage | Monness Crespi & Hardt | Neutral | |
2014-03-18 | Upgrade | KeyBanc | Hold to Buy | $86.00 |
2013-11-26 | Boost Price Target | Mizuho | Buy | $83.00 to $98.00 |
2013-11-21 | Reiterated Rating | Citigroup Inc. | Buy | $84.00 to $92.00 |
2013-11-21 | Downgrade | Avondale Partners | Outperform to Market Perform | |
2013-11-08 | Initiated Coverage | FBR & Co. | Outperform | $94.00 |
2013-11-01 | Boost Price Target | RBC Capital | Outperform | $75.00 to $84.00 |
2013-10-31 | Boost Price Target | Barclays | Overweight | $83.00 to $90.00 |
2013-10-31 | Reiterated Rating | BMO Capital Markets | Market Perform | $70.00 to $75.00 |
2013-10-30 | Boost Price Target | Credit Suisse | Outperform | $77.00 to $89.00 |
2013-10-15 | Reiterated Rating | Deutsche Bank | Buy | $88.00 |
2013-10-15 | Boost Price Target | Susquehanna | Buy | $71.00 to $80.00 |
2013-10-08 | Initiated Coverage | Goldman Sachs | Neutral to Buy | $87.00 |
2013-10-07 | Boost Price Target | Deutsche Bank | Buy | $79.00 to $88.00 |
2013-04-30 | Reiterated | Mizuho | Buy | $64 to $72 |
2013-03-04 | Reiterated | Mizuho | Buy | $60 to $64 |
2013-03-04 | Downgrade | WallachBeth | Buy to Hold | $61 |
2013-01-18 | Downgrade | Standpoint Research | Buy to Hold |
2016-06-29 | Reiterated Rating | Credit Suisse | Hold | $140.00 |
2016-06-29 | Reiterated Rating | Credit Suisse Group AG | Hold | $140.00 |
2016-06-13 | Upgrade | Ladenburg Thalmann | Not Rated to Outperform | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-16 | Reiterated Rating | Robert W. Baird | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In UHS 341 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 7.29M |
FMR LLC | 5.91M |
Invesco Ltd. | 4.96M |
BlackRock Inc. | 4.66M |
First Eagle Investment Management, LLC | 4.63M |
STATE STREET CORP | 2.89M |
AMERICAN CENTURY COMPANIES INC | 2.45M |
BlackRock Institutional Trust Company, N.A. | 2.38M |
Camber Capital Management LLC | 2.25M |
BlackRock Fund Advisors | 1.88M |
JANUS CAPITAL MANAGEMENT LLC | 1.76M |
NUANCE INVESTMENTS, LLC | 1.72M |
DIMENSIONAL FUND ADVISORS LP | 1.64M |
GEODE CAPITAL MANAGEMENT, LLC | 1.51M |
LSV ASSET MANAGEMENT | 1.24M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
FILTON STEVE Senior Vice President & CFO | 4.97% (327492) | UHS / |
OSTEEN DEBRA K Senior Vice President | 1.59% (104961) | UHS / |
MILLER ALAN B Chairman and CEO | 0.79% (51933) | UHS / UHT / |
Miller Marc D President | 0.79% (51933) | PINC / UHS / UHT / |
Pember Marvin G. Senior Vice President | 0.72% (47568) | UHS / |
HOTZ ROBERT H | 0.70% (46161) | PBY / UHS / |
HERRELL JOHN H | 0.25% (16633) | UHS / |
McDonnell Eileen C. | 0.11% (7509) | UHS / |
DUCAT LEATRICE | 0.06% (4000) | UHS / |
Gibbs Lawrence S. | 0.06% (3754) | UHS / |
PANTALEONI ANTHONY | 0.03% (1794) | UHS / |